J. Cell Biol.
© The Rockefeller University Press
0021-9525/97/07/435/14 $2.00
Volume 138, Number 2, July 28, 1997 435-448

Cellular Localization, Expression, and Structure of the Nuclear Dot Protein 52

Thomas Sternsdorf, Kirsten Jensen, Dirk Züchner, and Hans Will

Heinrich-Pette-Institut für experimentelle Virologie und Immunologie an der Universität Hamburg, D-20251 Hamburg, FRG

Nuclear dots containing PML and Sp100 proteins (NDs) play a role in the development of acute promyelocytic leukemia, are modified after infection with various viruses, and are autoimmunogenic in patients with primary biliary cirrhosis (PBC). PML and Sp100 gene expression is strongly enhanced by interferons (IFN). Based on immunostaining with a monoclonal antibody (mAb C8A2), a third protein, nuclear dot protein 52 (NDP52), was recently localized in NDs. Here we analyzed the cellular localization, expression, and structure of NDP52 in more detail. Our NDP52-specific sera revealed mainly cytoplasmic staining but no ND pattern, neither in untreated nor in IFN-treated cells. Cells transfected with NDP52 expression vectors showed exclusively cytoplasmic staining. In subcellular fractionation experiments, NDP52 was found in cytoplasmic and nuclear fractions. Unlike as described for Sp100 and PML, NDP52 mRNA and protein levels were only marginally enhanced by IFN  and not enhanced at all by IFN . NDP52 homodimerization but no heterodimerization with Sp100 or PML could be demonstrated. None of the 93 PBC sera tested contained autoantibodies against NDP52. Finally, mAb C8A2 reacted not only with NDP52 but also with a conformation-dependent epitope on the Sp100 protein. These data imply that NDP52 forms homodimers but no heterodimers with Sp100 and PML, lacks autoantigenicity in PBC, localizes mainly in the cytoplasm, and is associated with the nucleus, but not with NDs. Finally, unlike Sp100 and PML, NDP52 expression is neither markedly enhanced nor localization detectably altered by type I and II IFNs.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Xing, Z., Cardona, C. J., Adams, S., Yang, Z., Li, J., Perez, D., Woolcock, P. R. (2009). Differential regulation of antiviral and proinflammatory cytokines and suppression of Fas-mediated apoptosis by NS1 of H9N2 avian influenza virus in chicken macrophages. J. Gen. Virol. 90: 1109-1118 [Abstract] [Full Text]  
• Morriswood, B., Ryzhakov, G., Puri, C., Arden, S. D., Roberts, R., Dendrou, C., Kendrick-Jones, J., Buss, F. (2007). T6BP and NDP52 are myosin VI binding partners with potential roles in cytokine signalling and cell adhesion. J. Cell Sci. 120: 2574-2585 [Abstract] [Full Text]  
• Chin, K.-T., Chun, A. C.S., Ching, Y.-P., Jeang, K.-T., Jin, D.-Y. (2007). Human T-Cell Leukemia Virus Oncoprotein Tax Represses Nuclear Receptor-Dependent Transcription by Targeting Coactivator TAX1BP1. Cancer Res. 67: 1072-1081 [Abstract] [Full Text]  
• Xing, Z., Conway, E. M., Kang, C., Winoto, A. (2004). Essential Role of Survivin, an Inhibitor of Apoptosis Protein, in T Cell Development, Maturation, and Homeostasis. JEM 199: 69-80 [Abstract] [Full Text]  
• Di, Y., Li, J., Zhang, Y., He, X., Lu, H., Xu, D., Ling, J., Huo, K., Wan, D., Li, Y.-Y., Gu, J. (2003). HCC-Associated Protein HCAP1, a Variant of GEMIN4, Interacts with Zinc-Finger Proteins. J Biochem 133: 713-718 [Abstract] [Full Text]  
• Gurung, R., Tan, A., Ooms, L. M., McGrath, M. J., Huysmans, R. D., Munday, A. D., Prescott, M., Whisstock, J. C., Mitchell, C. A. (2003). Identification of a Novel Domain in Two Mammalian Inositol-polyphosphate 5-Phosphatases That Mediates Membrane Ruffle Localization. THE INOSITOL 5-PHOSPHATASE SKIP LOCALIZES TO THE ENDOPLASMIC RETICULUM AND TRANSLOCATES TO MEMBRANE RUFFLES FOLLOWING EPIDERMAL GROWTH FACTOR STIMULATION. J. Biol. Chem. 278: 11376-11385 [Abstract] [Full Text]  
• Melnick, A., Licht, J. D. (1999). Deconstructing a Disease: RAR{alpha}, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia. Blood 93: 3167-3215 [Full Text]  
• Sternsdorf, T., Jensen, K., Reich, B., Will, H. (1999). The Nuclear Dot Protein Sp100, Characterization of Domains Necessary for Dimerization, Subcellular Localization, and Modification by Small Ubiquitin-like Modifiers. J. Biol. Chem. 274: 12555-12566 [Abstract] [Full Text]  
• Guldner, H., Szostecki, C, Schroder, P, Matschl, U, Jensen, K, Luders, C, Will, H, Sternsdorf, T (1999). Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif. J. Cell Sci. 112: 733-747 [Abstract]  
• Lamond, A. I., Earnshaw, W. C. (1998). Structure and Function in the Nucleus. Science 280: 547-553 [Abstract] [Full Text]  
• Sternsdorf, T., Jensen, K., Will, H. (1997). Evidence for Covalent Modification of the Nuclear Dot-associated Proteins PML and Sp100 by PIC1/SUMO-1. JCB 139: 1621-1634 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents